The Economic Times

KKR-owned Healthium, Temasek-backed Romsons in race to buy 70-80% stake in BL Lifesciences

KKR-owned Healthium Medtech and Romsons Group are reportedly competing to acquire a significant stake in BL Lifesciences. The company is expected to be valued between 1,800 and 2,000 crore during this stake sale. KPMG is providing advisory services to the promoters of BL Lifesciences for this transaction, which involves a family-owned business. BL Lifesciences specializes in various medical devices for surgeries, critical care, and more.